List of insiders holdings for Celularity Inc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| STARR INTERNATIONAL CO INC Starr International Investments Ltd. 10% Owner | 2023-02-13 17:13:31 | 15,281,389 0 | 15,281,389 | Form 13G |
| GX Sponsor LLC 10% Owner | 2021-07-20 21:34:58 | 14,187,500 0 | 14,187,500 | Form 4 |
| Sorrento Therapeutics Inc. 10% Owner | 2023-10-05 17:22:14 | 5,050,427 0 | 5,050,427 | Form 13G |
| Resorts World Inc Pte. Ltd. 10% Owner | 2024-12-19 21:49:11 | 3,600,000 0 | 3,600,000 | Form 3 |
| Lim Kok Thay Dragasac Ltd Genting Berhad 10% Owner | 2024-12-19 21:16:22 | 3,600,000 0 | 3,600,000 | Form 13D |
| Hariri Robert J Chief Executive Officer | 2024-04-16 20:56:09 | 2,855,889 0 | 2,855,889 | Form 4 |
| Pecora Andrew L President | 2021-09-17 14:48:53 | 2,469,282 0 | 2,469,282 | Form 4 |
| Diamandis Peter Director | 2023-06-16 20:48:59 | 1,584,844 0 | 1,584,844 | Form 4 |
| Lim Kok Thay Genting Berhad 10% Owner | 2024-12-19 21:19:04 | 2,531 1,350,000 | 1,352,531 | Form 4 |
| Kilcoyne Adrian Chief Medical Officer | 2024-02-21 21:38:15 | 1,327,451 0 | 1,327,451 | Form 4 |
| SCULLEY JOHN Director | 2023-06-16 21:01:18 | 1,282,438 0 | 1,282,438 | Form 4 |
| Ling Geoffrey M.D. Director | 2023-10-16 20:06:20 | 1,250,000 0 | 1,250,000 | Form 4 |
| VON ESCHENBACH ANDREW C. Director | 2023-06-16 21:02:25 | 613,844 0 | 613,844 | Form 4 |
| Mazur Marc Director | 2023-06-16 21:02:41 | 513,844 0 | 513,844 | Form 4 |
| Parks Diane L. Director | 2023-06-16 21:04:57 | 513,844 0 | 513,844 | Form 4 |
| Kehler Dean C Director | 2023-06-16 21:03:27 | 513,844 0 | 513,844 | Form 4 |
| Smith Robin L Director | 2023-06-16 21:02:47 | 513,844 0 | 513,844 | Form 4 |
| Glover Bradley See Remarks | 2023-04-17 21:12:44 | 351,192 0 | 351,192 | Form 4 |
| Mirakhur Beloo EVP, Clinical Development | 2021-09-15 18:50:54 | 125,000 0 | 125,000 | Form 4 |
| BERMAN RICHARD J Director | 2024-08-28 17:26:27 | 118,111 0 | 118,111 | Form 4 |
| Dunn Keary See Remarks | 2022-04-28 21:04:29 | 64,505 0 | 64,505 | Form 4 |
| Bloom Jay R Director | 2021-09-13 18:03:21 | 56,053 0 | 56,053 | Form 4 |
| Jones Anne Chief Business Officer | 2022-11-18 20:16:41 | 49,154 0 | 49,154 | Form 4 |
| Haines John R See Remarks | 2024-04-16 20:56:12 | 38,373 0 | 38,373 | Form 4 |
| Beers David C Chief Financial Officer | 2024-04-16 20:56:11 | 23,983 0 | 23,983 | Form 4 |
| Fletcher Kyle See Remarks | 2024-04-16 20:56:13 | 21,085 0 | 21,085 | Form 4 |
| Brigido Stephen Pres, Functional Regeneration | 2024-04-16 20:56:08 | 19,472 0 | 19,472 | Form 4 |
| Kellett Andrea J. Chief Financial Officer | 2019-05-20 21:38:41 | 0 0 | 0 | Form 3 |
| Weinberger Hillel Director | 2019-05-20 21:40:12 | 0 0 | 0 | Form 3 |
| Maselli Michael G Vice President of Acquisitions | 2019-05-20 21:39:29 | 0 0 | 0 | Form 3 |
| LEVY PAUL S Director | 2019-05-20 21:39:04 | 0 0 | 0 | Form 3 |